Skip to main content
SymBio Pharmaceuticals Limited logo

SymBio Pharmaceuticals Limited — Investor Relations & Filings

Ticker · 4582 ISIN · JP3383050006 T Manufacturing
Open in API
Filings indexed 87 across all filing types
Latest filing 2023-04-28 Interim / Quarterly Rep…
Country JP Japan
Listing T 4582

About SymBio Pharmaceuticals Limited

https://www.symbiopharma.com/en/

SymBio Pharmaceuticals Limited is a specialty pharmaceutical company focused on the development and commercialization of new drug candidates. The company's business model involves acquiring development and marketing rights for promising pharmaceuticals from other bio-ventures and pharmaceutical firms to address unmet medical needs. Its core therapeutic areas include oncology, hematology, and rare diseases. A key product in its portfolio is bendamustine hydrochloride (Treakisym), an agent used in the treatment of hematologic cancers such as low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. SymBio aims to deliver innovative treatments to patients by advancing its pipeline of specialized drugs.

Recent filings

Filing Released Lang Actions
四半期報告書－第19期第1四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet and management analysis for the first quarter of the 19th fiscal period (January 1, 2023, to March 31, 2023). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q1 2023
2023-04-28 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically confirming the accuracy of a previously filed Annual Securities Report (Yukashoken Hokokusho). Since it is a formal regulatory filing confirming the validity of financial reporting and does not fit into the specific categories of an Annual Report or Earnings Release, it falls under the general regulatory filing category. FY 2022
2023-03-24 Japanese
訂正有価証券報告書－第18期(2022/01/01－2022/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2022. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act. FY 2022
2023-03-24 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a mandatory document in Japan that accompanies an Annual Securities Report (Yuuka Shouken Houkokusho) to confirm the accuracy of the financial statements. Since it is a regulatory filing confirming the validity of the annual report and does not contain the full financial report itself, it falls under the general regulatory filing category. FY 2022
2023-03-23 Japanese
内部統制報告書－第18期(2022/01/01－2022/12/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. This type of document is a specific regulatory requirement for public companies in Japan and falls under the category of Audit Report / Information (AR) as it pertains to the assessment of internal controls and audit-related compliance.
2023-03-23 Japanese
有価証券報告書－第18期(2022/01/01－2022/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, business overview, and management information for the fiscal year ending December 31, 2022. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau, not an announcement or a summary. FY 2022
2023-03-23 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.